Replies to post #276057 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

For "them," not enough.

If you had to predict how this news will play out in academia, NIH, BP...what news-PR-pub-other, would you be looking for next???

External press accounts of the Anavex Parkinson's disease dementia clinical trial results will be have statements similar to this:

"Professor Dorglemeyer at Harvard stated, 'Although thought to be positive (no actual data were released), results from the Anavex clinical trial must be understood to be merely preliminary. The drug cannot be approved for use until further, replicated clinical trials are performed.'"

Now, if the study were run by a "real" pharmaceutical, such as Biogin, everything positive would have been in the headline: "New Drug Can Treat Parkinson's. Very Safe, Effective."

Biogin is headquartered in Cambridge, MA. Only smart people live and work there. "Anavex? Who ever heard of them?"

[JWC3]

You and falconer have it right. Missling said so this morning. The A 2-73 MOA has been VALIDATED by the PDD results this morning!